Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.759,68
0,41%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Freeline Therapeutics Holdings PLC (FRLN) Freeline Therapeutics Holdings PLC (FRLN) Notizie

FRLN

Freeline Therapeutics (FRLN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FRLN
DataOraFonteTitoloSimboloCompagnia
24/04/202422:00GlobeNewswire Inc.Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:FRLNFreeline Therapeutics Holdings PLC
26/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FRLNFreeline Therapeutics Holdings PLC
22/02/202422:38Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FRLNFreeline Therapeutics Holdings PLC
22/02/202422:28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FRLNFreeline Therapeutics Holdings PLC
20/02/202421:22Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NASDAQ:FRLNFreeline Therapeutics Holdings PLC
20/02/202413:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:FRLNFreeline Therapeutics Holdings PLC
20/02/202413:00GlobeNewswire Inc.Acquisition of Freeline by Syncona Becomes EffectiveNASDAQ:FRLNFreeline Therapeutics Holdings PLC
12/02/202418:00GlobeNewswire Inc.Freeline Shareholders Approve Acquisition by SynconaNASDAQ:FRLNFreeline Therapeutics Holdings PLC
08/12/202323:21Edgar (US Regulatory)Form SC 13E3 - Going private transaction by certain issuersNASDAQ:FRLNFreeline Therapeutics Holdings PLC
22/11/202313:30GlobeNewswire Inc.Syncona to Acquire Freeline TherapeuticsNASDAQ:FRLNFreeline Therapeutics Holdings PLC
25/10/202308:01GlobeNewswire Inc.Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual CongressNASDAQ:FRLNFreeline Therapeutics Holdings PLC
16/10/202313:00GlobeNewswire Inc.Freeline to Present New Clinical Data for FLT201 in Gaucher Disease in Oral Presentation at Upcoming ESGCT 30th Annual CongressNASDAQ:FRLNFreeline Therapeutics Holdings PLC
04/10/202313:00GlobeNewswire Inc.Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher DiseaseNASDAQ:FRLNFreeline Therapeutics Holdings PLC
15/08/202313:00GlobeNewswire Inc.Freeline Reports Second Quarter 2023 Financial Results and Business HighlightsNASDAQ:FRLNFreeline Therapeutics Holdings PLC
08/08/202313:30GlobeNewswire Inc.Freeline Therapeutics to Host Second Quarter 2023 Financial Results CallNASDAQ:FRLNFreeline Therapeutics Holdings PLC
31/07/202313:30GlobeNewswire Inc.Freeline to Participate in Upcoming Investor ConferencesNASDAQ:FRLNFreeline Therapeutics Holdings PLC
25/07/202313:30GlobeNewswire Inc.Freeline to Host Virtual KOL Event on its Gene Therapy Candidate, FLT201, in Gaucher DiseaseNASDAQ:FRLNFreeline Therapeutics Holdings PLC
26/06/202313:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FRLNFreeline Therapeutics Holdings PLC
26/06/202313:30GlobeNewswire Inc.Freeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson’s DiseaseNASDAQ:FRLNFreeline Therapeutics Holdings PLC
02/06/202314:00GlobeNewswire Inc.Freeline to Present at 2023 Jefferies Healthcare ConferenceNASDAQ:FRLNFreeline Therapeutics Holdings PLC
30/05/202313:30GlobeNewswire Inc.Freeline Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:FRLNFreeline Therapeutics Holdings PLC
22/05/202314:00GlobeNewswire Inc.Freeline Granted ILAP Designation in United Kingdom by MHRA for FLT201, an Investigational Gene Therapy for the Treatment of Gaucher DiseaseNASDAQ:FRLNFreeline Therapeutics Holdings PLC
12/05/202314:05GlobeNewswire Inc.Freeline Completes ADS Ratio ChangeNASDAQ:FRLNFreeline Therapeutics Holdings PLC
21/04/202314:54Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)NASDAQ:FRLNFreeline Therapeutics Holdings PLC
21/04/202313:00GlobeNewswire Inc.Freeline Announces Proposed ADS Ratio ChangeNASDAQ:FRLNFreeline Therapeutics Holdings PLC
12/04/202314:00GlobeNewswire Inc.Freeline to Present at 22nd Annual Needham Virtual Healthcare ConferenceNASDAQ:FRLNFreeline Therapeutics Holdings PLC
04/04/202313:03Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:FRLNFreeline Therapeutics Holdings PLC
04/04/202313:00GlobeNewswire Inc.Freeline Reports Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:FRLNFreeline Therapeutics Holdings PLC
28/03/202313:00GlobeNewswire Inc.Freeline Therapeutics to Host Full Year 2022 Financial Results CallNASDAQ:FRLNFreeline Therapeutics Holdings PLC
14/02/202319:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FRLNFreeline Therapeutics Holdings PLC
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FRLN

La tua Cronologia

BIT
UCG
Unicredit
BIT
TIT
Telecom Italia
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TITR
Telecom Italia
BIT
ENEL
Enel
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
PIRC
Pirelli & C
BIT
SPM
Saipem
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network